期刊文献+

低分子肝素联合小剂量尿激酶治疗肾病综合征16例疗效观察 被引量:2

下载PDF
导出
摘要 目的观察低分子肝素联合小剂量尿激酶治疗肾病综合征的临床疗效。方法将32例原发性肾病综合征患者随机分为A组和B组。A组16例在应用激素等常规治疗的同时应用低分子肝素4100单位皮下注射2次/日,尿激酶10万单位静滴1次/日,总共治疗4周;并与常规治疗B组对照。结果A组总有效率87.5%,B组总有效率56.25%,有统计学差异(P<0.01).结论加用低分子肝素和小剂量尿激酶治疗肾病综合征无明显副作用,并有较好的治疗效果。
机构地区 清流县医院
出处 《社区医学杂志》 2007年第07S期40-41,共2页 Journal Of Community Medicine
  • 相关文献

参考文献3

二级参考文献11

  • 1[1]Vassalli JD,Sappino AP,Belin D.The plasminogen activator/plasmin system.J Clin Invest,1991;88:1067~72
  • 2[2]Xu Y,Hagege J,Mougenot B et al.Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney.Kidney Int,1996;50:2011~9
  • 3[3]Yamamoto K,Loskutoff DJ,Saitor H.Renal expression of fibrinolytic genes and tissue factor in a murine model of renal disease as a function of age.Semin Thromb Heamost,1998;24(3):261~8
  • 4[4]Aya N,Yoshioka K,Murakami K et al.Tissue-type plasminogen activator and its inhibitor in human glomerulonephritis.J Pathol,1992;166(3):289~95
  • 5[5]Colucci M, Semeraro N, Montemurro P et al.Urinary procoagulant and fibrinolytic activity in human glomerulonephri-tis.Relationship with renal function.Kidney Int,1991;39:1213~7
  • 6[7]叶应妩,李健斋,王玉琛主编. 临床实验诊断学(上册).北京:人民出版社,1988:1159~64
  • 7[8]Lee SM, Rao VM,Franklin W et al.IgA nephropathy: morphologic predictors of progressive renal disease.Hum Pathol,1982;13(4):314~22
  • 8[9]Floege J,Eng E,Linder V et al.Rat glomerular mesangial cell synthesize basic fibroblast growth factor. Release,upregulated synthesis and mitogenicity in mesangial proliferative glomerulonephritis.J Clin Invest,1992;90:2362~9
  • 9[10]Wagner SN,Atkinson MJ,Wagner C et al.Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney.Histochem Cell Biol,1996;105(1):53~60
  • 10Sang Q X,Cell Res,1998年,8卷,171页

共引文献72

同被引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部